IL-6 발현 억제를 위한 siRNA 및 이를 함유하는조성물
    1.
    发明公开
    IL-6 발현 억제를 위한 siRNA 및 이를 함유하는조성물 无效
    用于抑制IL-6表达和组合的SIRNA

    公开(公告)号:KR1020060119412A

    公开(公告)日:2006-11-24

    申请号:KR1020050042427

    申请日:2005-05-20

    CPC classification number: C12N15/1136 C12N2310/14

    Abstract: A small interfering RNA(siRNA) and a pharmaceutical composition comprising the same are provided to be able to decrease the interleukin-6(IL-6) level, thereby being useful for treating inflammatory diseases, auto-immune diseases, tumor diseases or central nervous system diseases related with excessively generated IL-6. The double stranded siRNA is selected from the group consisting of SEQ ID : NO. 1 and a complementary sequence thereof described as SEQ ID : NO. 4, SEQ ID : NO. 2 and a complementary sequence thereof described as SEQ ID : NO. 5, and SEQ ID : NO. 3 and a complementary sequence thereof described as SEQ ID : NO. 6. The pharmaceutical composition for inhibiting expression of IL-6 or treating inflammatory diseases, auto-immune diseases, tumor diseases or central nervous system diseases comprises the siRNA or a mixture thereof.

    Abstract translation: 提供小干扰RNA(siRNA)和包含其的药物组合物以能够降低白细胞介素-6(IL-6)水平,从而可用于治疗炎性疾病,自身免疫疾病,肿瘤疾病或中枢神经 与过度生成IL-6相关的系统疾病。 双链siRNA选自SEQ ID NO: 1及其互补序列如SEQ ID NO: 4,SEQ ID NO: 2及其互补序列,如SEQ ID NO: 5和SEQ ID NO: 3及其互补序列,如SEQ ID NO: 用于抑制IL-6表达或治疗炎性疾病,自身免疫疾病,肿瘤疾病或中枢神经系统疾病的药物组合物包含siRNA或其混合物。

Patent Agency Ranking